Evidence map›Paper›PMID 25538705›Full record

ReviewFrontiers in immunology2014

Macrophage: SHIP of Immunity.

Charles D Mills, Anita C Thomas, Laurel L Lenz, Markus Munder

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Macrophages in osteoarthritis: pathophysiology and therapeutics.American journal of translational research · 2020
    Article
  14. Molecular Crosstalk Between Macrophages and Mesenchymal Stromal Cells.Frontiers in cell and developmental biology · 2020
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Charles D MillsBioMedical Consultants , Marine on St. Croix, MN , USA.
Anita C ThomasBristol Heart Institute and Bristol CardioVascular, University of Bristol , Bristol , UK.
Laurel L LenzImmunology and Microbiology Department, University of Colorado School of Medicine , Aurora, CO , USA.
Markus MunderThird Department of Medicine, University Medical Center, Johannes Gutenberg University , Mainz , Germany.

Funding

Immune Modulation by Bacterial AutolysinsR01AI065638 · NIAID · UNIVERSITY OF COLORADO DENVER · PI LENZ, LAUREL L · 2006 to 2016
$3.8M
IFNGR Down Regulation as a Host Target for Therapy of Infectious DiseasesR33AI102264 · NIAID · UNIVERSITY OF COLORADO DENVER · PI LENZ, LAUREL L · 2014 to 2016
$1.1M
NIAID NIH HHS R01 AI065638NIAID NIH HHS R33 AI102264
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

arginasecanceriNOSM1M2macrophagenitric oxidewound

Identifiers

PMID25538705
PMCPMC4255611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.